Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Intravenous Autologous CD19 CAR-T Cells for R/ R MM, B-ALL, and B-Cell Lymphoma — Stella

Home/Lymphoblastic Leukemia/Intravenous Autologous CD19 CAR-T Cells for R/ R MM, B-ALL, and B-Cell Lymphoma

View on ClinicalTrials.gov

Recruiting

Back to Lymphoblastic Leukemia trials

Intravenous Autologous CD19 CAR-T Cells for R/ R MM, B-ALL, and B-Cell Lymphoma

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

China

The First Affiliated Hospital of University of Science and Technology of China, Hefei

Key details

Sponsor

Anhui Provincial Hospital

Enrollment target

~18 participants

Started

April 2025

Primary completion

August 2028

Age range

3 Years and older

Last updated May 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.